Itraconazole (Sporanox) in superficial and systemic fungal infections.
about
CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.Aspergillus fumigatus and related species.Molecular aspects of azoles-induced teratogenesis.Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Biomonitoring of the Genotoxic and Hepatotoxic Effects and Oxidative Stress Potentials of Itraconazole in Pregnant Rats.In utero exposure to itraconazole during different gestational periods of rats.
P2860
Itraconazole (Sporanox) in superficial and systemic fungal infections.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Itraconazole (Sporanox) in superficial and systemic fungal infections.
@ast
Itraconazole (Sporanox) in superficial and systemic fungal infections.
@en
type
label
Itraconazole (Sporanox) in superficial and systemic fungal infections.
@ast
Itraconazole (Sporanox) in superficial and systemic fungal infections.
@en
prefLabel
Itraconazole (Sporanox) in superficial and systemic fungal infections.
@ast
Itraconazole (Sporanox) in superficial and systemic fungal infections.
@en
P2860
P356
P1476
Itraconazole (Sporanox) in superficial and systemic fungal infections.
@en
P2093
P2860
P304
P356
10.1586/14787210.1.4.531
P577
2003-12-01T00:00:00Z